The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells. The gene discussed is NUDT1; the disease is neuroendocrine neoplasm.